Pancreatic cancer is one of the worst cancer in the worlds.
This cancer is hard to diagnose in the early stage, so we often have no way to treat the patients when the cancer is found.
Today's BBC said that combination therapy of gemcitabine and MRK300 could work well.
Of course, this result was showed in the experimental animals, so we have to confirm this effect in human.
However, this results gives the hope to all pancreatic cancer patients.
Scientists say they may have found a new weapon against pancreatic cancer after promising early trial results of an experimental drug combination.
Giving the chemotherapy agent gemcitabine with an experimental drug called MRK003 sets off a chain of events that ultimately kills cancer cells, studies in mice show.
Patients are now testing the treatment to see if it will work for them.
Pancreatic cancer: Trial drug MRK003 shows promise - BBC News
The Cancer Research UK-funded trials are being carried out in Cambridge.
Therefore, next target is the supreme diagnosis for early detection of pancreatic cancer.
